Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||
|---|---|---|---|---|---|---|
| RVMD | +2.32% | +3.30% | −8.94% | +0.34% | +34.91% | +101.88% |
| LHLONGEVITY | +1.57% | +3.96% | +1.43% | +1.77% | +8.63% | +11.21% |
| TGHRMF-A | +2.73% | +5.44% | +10.45% | +11.39% | +20.84% | +20.83% |
| KFHEALTH-A | +2.38% | +5.55% | +10.34% | +9.33% | +20.76% | +19.76% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes RVMD: money market or bond funds, or no holdings data yet
| TGHRMF-A | KFHEALTH-A | |
|---|---|---|
| Held by both | ||
 Eli Lilly and Co | 10.15% | 7.92% |
 Johnson & Johnson | 6.99% | 6.24% |
 ABBVIE | 5.07% | 7.23% |
 Merck & | 4.22% | 5.25% |
 Unitedhealth Group | 3.88% | 3.27% |
 Thermo Fisher | 2.94% | 4.56% |
 AstraZeneca | 2.32% | 4.06% |
| Only in TGHRMF-A | ||
 Amgen | 3.34% | N/A |
 Roche | 2.70% | N/A |
 Novartis AG Registered Shares | 2.41% | N/A |
| Only in KFHEALTH-A | ||
 Novartis | N/A | 4.46% |
 Abbott Laboratories | N/A | 2.87% |
 Danaher | N/A | 2.87% |
26 Mar 2026 → 2 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| RVMD | +101.88% | 69.11% | 1.47 |
| TGHRMF-A | +20.83% | 16.31% | 1.28 |
| KFHEALTH-A | +19.76% | 15.90% | 1.24 |
| LHLONGEVITY | +11.21% | 22.33% | 0.50 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | RVMD | LHLONGEVITY | TGHRMF-A | KFHEALTH-A |
|---|---|---|---|---|
Fund details | ||||
| Fund size | N/A | 75.68 million | 138 million | 671 million |
| Inception date | N/A | 27 Mar 2026 | 1 Sep 2015 | 1 Aug 2014 |
| Master fund | N/A | Tema Oncology ETF | กองทุนที่ลงทุนหลายกอง (ISHARES GLOBAL HEALTHCARE, State Street Health Care Select Sector SPDR, ISHARES BIOTECHNOLOGY) | JPMorgan Funds - Global Healthcare Fund |
| Dividend policy | N/A | Does not pay | Does not pay | Does not pay |
Risk and currency hedging | ||||
| Risk level | N/A | 7 | 7 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 79.91% | 90.96% | 0.00% |
Minimum purchase and redemption | ||||
| First purchase | N/A | 1,000 THB | 1,000 THB | 500 THB |
| Subsequent purchase | N/A | 100 THB | 1,000 THB | 500 THB |
| Redemption (amount) | N/A | No minimum | No minimum | 500 THB |
| Redemption (units) | N/A | No minimum | No minimum | 50 units |
| Balance (amount) | N/A | 100 THB | No minimum | No minimum |
| Balance (units) | N/A | No minimum | No minimum | 50 units |
Order cut-off and redemption payment | ||||
| Buy before | N/A | 15:30 | 15:30 | 15:30 |
| Redeem before | N/A | 15:30 | 15:30 | 14:30 |
| Redemption paid | N/A | T+2 | T+3 | T+4 |
